Published in Genes Immun on August 01, 2005
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet (2007) 2.77
A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet (2009) 2.45
Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet (2010) 1.45
Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol (2007) 1.39
Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. Autoimmunity (2010) 1.12
Kawasaki disease: novel insights into etiology and genetic susceptibility. Annu Rev Med (2011) 1.08
Genetic polymorphisms in Kawasaki disease. Acta Pharmacol Sin (2011) 0.98
Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease. J Hum Genet (2010) 0.96
Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease. Clin Exp Immunol (2007) 0.91
Kawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort study. BMC Pediatr (2013) 0.91
Increased risk of atopic dermatitis in preschool children with kawasaki disease: a population-based study in taiwan. Evid Based Complement Alternat Med (2013) 0.90
Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension. PLoS One (2011) 0.87
Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children. PLoS One (2010) 0.84
Understanding the pathogenesis of Kawasaki disease by network and pathway analysis. Comput Math Methods Med (2013) 0.84
Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study. PLoS One (2012) 0.83
Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran. Iran J Pediatr (2014) 0.81
Gene-Gene Associations with the Susceptibility of Kawasaki Disease and Coronary Artery Lesions. PLoS One (2015) 0.79
Elevated Serum Levels of IL-21 in Kawasaki Disease. Allergy Asthma Immunol Res (2012) 0.79
Comparison of the laboratory data between Kawasaki disease and enterovirus after intravenous immunoglobulin treatment. Pediatr Cardiol (2012) 0.77
Association between Kawasaki disease and autism: a population-based study in Taiwan. Int J Environ Res Public Health (2014) 0.77
Interleukin-6 (-636 c/g) gene polymorphism in korean children with kawasaki disease. Korean Circ J (2011) 0.77
Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease. Yonsei Med J (2018) 0.75
Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet (1993) 51.42
PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet (1998) 23.25
High-resolution haplotype structure in the human genome. Nat Genet (2001) 20.51
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
GOLD--graphical overview of linkage disequilibrium. Bioinformatics (2000) 9.43
[Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi (1967) 9.06
Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation (1996) 7.29
Kawasaki syndrome. Lancet (2004) 5.09
Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science (1994) 3.57
Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics (2003) 2.36
Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy (1995) 2.14
A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res (1999) 2.13
Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J (1994) 1.99
Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr (1998) 1.84
Kawasaki disease: A brief history. Pediatrics (2000) 1.63
Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology (2005) 1.59
Structure and function of Fc receptors for IgE on lymphocytes, monocytes, and macrophages. Adv Immunol (1984) 1.54
Elevated levels of immunoglobulin E in the acute febrile mucocutaneous lymph node syndrome. Pediatr Res (1976) 1.48
Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan. Pediatrics (1977) 1.48
Use of buccal cells collected in mouthwash as a source of DNA for clinical testing. Arch Pathol Lab Med (2001) 1.42
Kawasaki disease in parents and children. Acta Paediatr (2003) 1.37
Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat Rev Immunol (2003) 1.32
A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis (2002) 1.32
Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998. Pediatr Infect Dis J (2000) 1.29
Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. J Allergy Clin Immunol (2000) 1.25
A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol (2003) 1.21
Commentary: translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967. Pediatr Infect Dis J (2002) 1.20
Polymorphisms of the IL-4, TNF-alpha, and Fcepsilon RIbeta genes and the risk of allergic disorders in at-risk infants. Am J Respir Crit Care Med (2000) 1.15
Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease. Pharmacogenomics J (2002) 1.14
Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr (2001) 1.12
Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease. Clin Exp Immunol (1995) 1.12
Tendency toward atopy in Kawasaki disease. Eur J Pediatr (1997) 1.12
Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child (1987) 1.09
High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol (1997) 1.06
Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet (1998) 1.05
Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease. Arthritis Rheum (2001) 1.04
Increased prevalence of atopic dermatitis in Kawasaki disease. Pediatr Infect Dis J (1988) 1.03
Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease. Lancet (2003) 1.02
Kawasaki disease in the United States. J Infect Dis (1978) 1.02
Expression of Fc epsilon R2/CD23 on peripheral blood macrophages/monocytes in Kawasaki disease. Clin Immunol Immunopathol (1990) 1.01
Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Pediatr Res (2001) 1.00
Decreased interferon-gamma (IFN-gamma)-producing T cells in patients with acute Kawasaki disease. Clin Exp Immunol (1999) 0.96
Circulating soluble selectins in Kawasaki disease. Clin Exp Immunol (1997) 0.94
High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm. Eur J Pediatr (1997) 0.91
A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J Pediatr (2003) 0.91
CD40 ligand gene and Kawasaki disease. Eur J Hum Genet (2004) 0.85
Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease). Ann Allergy (1987) 0.83
Increased expression of Fc epsilon R2/CD23 on peripheral blood B lymphocytes and serum IgE levels in Kawasaki disease. Int Arch Allergy Appl Immunol (1991) 0.83
The prevalence of allergy in Kawasaki disease. Allergy (1998) 0.83
Polymorphism of SLC11A1 (formerly NRAMP1) gene confers susceptibility to Kawasaki disease. J Infect Dis (2003) 0.82
Cell adhesion molecule expression in coronary artery aneurysms in acute Kawasaki disease. Pediatr Infect Dis J (2004) 0.79
Elevated immunoglobulin E in infantile polyarteritis nodosa. J Pediatr (1974) 0.78
Soluble CD23 antigen in Kawasaki disease and other acute febrile illnesses. Eur J Pediatr (1995) 0.77
Immunological studies on Kawasaki disease: II. Isolation and characterization of an immunosuppressive factor in acute phase sera. Clin Exp Immunol (1987) 0.76
Performance of four computer-based diagnostic systems. N Engl J Med (1994) 9.40
Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem (1996) 5.82
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1997) 5.24
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med (1986) 4.49
Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation (1995) 3.80
Array-based genomic resequencing of human leukemia. Oncogene (2010) 3.77
The relationship between managed care insurance and use of lower-mortality hospitals for CABG surgery. JAMA (2000) 3.75
Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications. JAMA (1995) 3.60
The EGF-CFC protein one-eyed pinhead is essential for nodal signaling. Cell (1999) 3.15
Environmental factors influencing the production of fusarenon-X, a cytotoxic mycotoxin of Fusarium nivale Fn 2B. Chem Pharm Bull (Tokyo) (1970) 3.10
Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation (1992) 3.04
Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet (1989) 2.86
Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr (1996) 2.77
Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev (1996) 2.76
Developmental and neurologic effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg (2001) 2.70
Developmental and neurological status of children at 4 years of age after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. Circulation (1999) 2.67
In-hospital mortality for surgical repair of congenital heart defects: preliminary observations of variation by hospital caseload. Pediatrics (1995) 2.60
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 2.57
Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum (1992) 2.56
Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J (1998) 2.53
Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci U S A (2000) 2.49
Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction. Circulation (2000) 2.42
Rapid-sequence intubation of the pediatric patient. Pediatric Emergency Medicine Committee of the American College of Emergency Physicians. Ann Emerg Med (1996) 2.40
Noninvasive tests in the initial evaluation of heart murmurs in children. N Engl J Med (1983) 2.39
Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg (1990) 2.37
Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol (1994) 2.35
Inhaled human insulin treatment in patients with type 2 diabetes mellitus. Ann Intern Med (2001) 2.32
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation (1997) 2.32
A mammalian helix-loop-helix factor structurally related to the product of Drosophila proneural gene atonal is a positive transcriptional regulator expressed in the developing nervous system. J Biol Chem (1995) 2.31
Superoxide anion release by human endothelial cells: synergism between a phorbol ester and a calcium ionophore. J Cell Physiol (1986) 2.26
Cytochrome c(2) is not essential for photosynthetic growth of Rhodopseudomonas capsulata. Proc Natl Acad Sci U S A (1986) 2.25
Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity. J Antibiot (Tokyo) (1970) 2.20
Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest (1997) 2.19
Lactation is associated with greater maternal bone size and bone strength later in life. Osteoporos Int (2011) 2.19
Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol (1996) 2.18
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A (1999) 2.17
Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration. J Antibiot (Tokyo) (1970) 2.15
PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest (1999) 2.14
Gamma globulin re-treatment in Kawasaki disease. J Pediatr (1993) 2.13
A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res (1999) 2.13
Rapid caspase-3 activation during apoptosis revealed using fluorescence-resonance energy transfer. EMBO Rep (2000) 2.12
Selecting SNPs in two-stage analysis of disease association data: a model-free approach. Ann Hum Genet (2000) 2.05
Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem (1994) 2.02
Purification and properties of HuD, a neuronal RNA-binding protein. J Biol Chem (1996) 2.00
Penicillamine hypersensitivity: successful desensitization of a patient with severe hepatic Wilson's disease. Am J Gastroenterol (1994) 1.99
In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative. Antimicrob Agents Chemother (Bethesda) (1969) 1.96
Liver disease associated with early syphilis. N Engl J Med (1971) 1.95
Studies on denitrification. IX. Nitrous oxide, its production and reduction to nitrogen. J Biochem (1968) 1.93
A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer. N Engl J Med (1994) 1.93
Insertion of a 5' truncated L1 element into the 3' end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy. J Clin Invest (1993) 1.92
A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol (1998) 1.91
Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology (2001) 1.91
Toxicological approaches to the metabolites of Fusaria. II. Isolation of fusarenon-X from the culture filtrate of Fusarium nivale Fn 2B. Jpn J Exp Med (1971) 1.88
Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. J Exp Med (1999) 1.88
Quantitative genome scan and Ordered-Subsets Analysis of autism endophenotypes support language QTLs. Mol Psychiatry (2005) 1.87
The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease. Pediatr Cardiol (2006) 1.86
Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr (1998) 1.84
Inhibitory effects of mycotoxins on the protein synthesis in rabbit reticulocytes. J Biochem (1969) 1.83
Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg (1997) 1.75
Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med (1986) 1.74
Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin Sci (Lond) (2001) 1.74
Acetylcholinesterase, I. Large-scale purification, homogeneity, and amino Acid analysis. Proc Natl Acad Sci U S A (1967) 1.72
Massive intra-hepatic and extra-hepatic bile cast formation after cholecystectomy. Gastrointest Endosc (1993) 1.70
Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun (2001) 1.67
Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ (2001) 1.67
Clinical and economic outcomes of individuals with severe peptic ulcer hemorrhage and nonbleeding visible vessel: an analysis of two prospective clinical trials. Am J Gastroenterol (1998) 1.66
Caveolin is an activator of insulin receptor signaling. J Biol Chem (1998) 1.66
HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med (1996) 1.66
Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J Biol Chem (1997) 1.66
Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol (1999) 1.66
Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression. Circ Res (1996) 1.65
Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry (2011) 1.65
Toxicological approaches to the metabolites of Fusaria. I. Screening of toxic strains. Jpn J Exp Med (1971) 1.64
Comparison of outcome when hypoplastic left heart syndrome and transposition of the great arteries are diagnosed prenatally versus when diagnosis of these two conditions is made only postnatally. Am J Cardiol (1999) 1.64
Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease. Eur J Pediatr (1994) 1.64
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
Is there any justification for the routine histological examination of straightforward cholecystectomy specimens? Ann R Coll Surg Engl (2007) 1.64
Kawasaki disease: A brief history. Pediatrics (2000) 1.63
Radioisotopic studies on renewal of opsin. Vision Res (1968) 1.63
Passive cigarette smoking and reduced HDL cholesterol levels in children with high-risk lipid profiles. Circulation (1997) 1.63
Gastrointestinal tract perforation: CT diagnosis of presence, site, and cause. Abdom Imaging (2005) 1.63
Open donor, laparoscopic donor and hand assisted laparoscopic donor nephrectomy: a comparison of outcomes. J Urol (2001) 1.62
The effects of a myocardial bridge on coronary atherosclerosis and ischaemia. J Pathol (1998) 1.62
Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis. J Thromb Haemost (2006) 1.61
Cognitive development after the Fontan operation. Circulation (2000) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr (1991) 1.60
Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene (2008) 1.59
Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice. Exp Anim (2001) 1.58
Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients. Am J Transplant (2013) 1.58